ON YOU MARK, GET SET, DETECT!
test and evaluation. Te milestone marked the culmination of 20 years of hard work and cooperation from countless stake- holders throughout the department, ultimately equipping the joint force with a key bio-detection capability to ensure warfighters are safer in CBRN-contested environments.
“Te JBTDS achieving Milestone C is a testament to the dedication and unwav- ering commitment of many stakeholders over the years and stands as an example of overcoming acquisition challenges,” said Col. Robert Carter, the previous joint project manager for CBRN Sensors. “Although we have come this far, the inno- vation required to stay the course and deploy this capability is still very much at the forefront.”
JBTDS SAMPLING
During a Product Manager Risk Reduction event at Aberdeen Proving Ground in October 2023, a Marine from CBIRF prepares a sample obtained from the JBTDS Detector/Collector for PCR identification using the Biomeme 3/9 ISP identifier.
MOVING FORWARD With Milestone C achieved, the JBTDS is now positioned for Full Rate Produc- tion within the next 24 to 30 months. However, the JBTDS’ journey is far from over. JPM CBRN Sensors will continue to improve the system’s identification capa- bility over the next 18 months.
deployments to homeland security and disaster response scenarios.
Te product’s reliability, availability and maintainability (RAM) sets it apart as well. Extensive testing and end-user feedback has been used to enhance the system’s performance to ensure its RAM will meet mission requirements, making it a more sustainable tool. Additionally, the system’s reliability supplies the warfighter with confidence in the results. Finally, the CBDP will continue to collaborate with interested stakeholders to ensure that the JBTDS remains at the forefront
28
of technology, through ongoing improve- ments and updates.
FINALLY—THE MILESTONE C ACCOMPLISHMENT Te project finally achieved Milestone C status in August 2023—a pinnacle accom- plishment for the JPEO–CBRND and its JPM CBRN Sensors team. It represents a critical decision point, signifying that the system has undergone rigorous test- ing and evaluation, proving its readiness for production and deployment, and offi- cially recognizing that it is prepared for the rigors of a multi-service operational
Since entering Milestone C, the JBTDS has shown improvement in identify- ing biological warfare agents at both low and high concentrations while undergo- ing testing at Dugway Proving Ground, Utah. Based on preliminary data, it is projected that the identifier will meet the full threshold requirement in fiscal year 2026. Te capability deployed to the force will be operationally effective and provide commanders confidence to make informed decisions to prevent or mitigate biological threats that may affect their troops.
In parallel, the JBTDS will continue to adapt to emerging threats and changing operational environments using an incre- mental approach to provide operationally
Army AL&T Magazine Fall 2024
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120
